blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2909180

EP2909180 - ETHYNYL DERIVATIVES AS MODULATORS OF MGLUR5 RECEPTOR ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.08.2017
Database last updated on 08.04.2026
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2015/35]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / JAESCHKE, Georg
Lerchenstrasse 76
CH-4059 Basel / CH
02 / LINDEMANN, Lothar
Jungstrasse 44
CH-4056 Basel / CH
03 / RICCI, Antonio
Hauptstrasse 54
CH-4127 Birsfelden / CH
04 / RUEHER, Daniel
14 rue des Fleurs
F-68480 Raedersdorf / FR
05 / STADLER, Heinz
Dornacherstrasse 154
CH-4053 Basel / CH
06 / VIEIRA, Eric
Lindenstrasse 9
CH-4402 Frenkendorf / CH
 [2015/35]
Representative(s)Poppe, Regina
F.Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2015/35]
Application number, filing date13783003.015.10.2013
[2015/35]
WO2013EP71500
Priority number, dateEP2012018894018.10.2012         Original published format: EP 12188940
[2015/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014060398
Date:24.04.2014
Language:EN
[2014/17]
Type: A1 Application with search report 
No.:EP2909180
Date:26.08.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 24.04.2014 takes the place of the publication of the European patent application.
[2015/35]
Type: B1 Patent specification 
No.:EP2909180
Date:05.10.2016
Language:EN
[2016/40]
Search report(s)International search report - published on:EP24.04.2014
ClassificationIPC:C07D213/81, C07D413/06, A61K31/4439, A61P25/24, A61P25/16, A61P1/00
[2015/35]
CPC:
C07D413/06 (EP,CN,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/06 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P43/00 (EP); C07D213/81 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/35]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ETHYNYLDERIVATE ALS MODULATOREN DER MGLUR5-REZEPTORAKTIVITÄT[2015/35]
English:ETHYNYL DERIVATIVES AS MODULATORS OF MGLUR5 RECEPTOR ACTIVITY[2015/35]
French:DÉRIVÉS D'ÉTHYNYLE COMME MODULATEURS DE L'ACTIVITÉ DES RÉCEPTEURS MGLUR5[2015/35]
Entry into regional phase18.05.2015National basic fee paid 
18.05.2015Designation fee(s) paid 
18.05.2015Examination fee paid 
Examination procedure18.05.2015Examination requested  [2015/35]
18.08.2015Amendment by applicant (claims and/or description)
20.05.2016Communication of intention to grant the patent
22.08.2016Fee for grant paid
22.08.2016Fee for publishing/printing paid
22.08.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.05.2016
Opposition(s)06.07.2017No opposition filed within time limit [2017/37]
Fees paidRenewal fee
07.10.2015Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.10.2013
AL05.10.2016
AT05.10.2016
BE05.10.2016
CY05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
MK05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
SM05.10.2016
IE15.10.2016
LU15.10.2016
MT31.10.2016
BG05.01.2017
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
[2020/34]
Former [2018/32]HU15.10.2013
AT05.10.2016
BE05.10.2016
CY05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
MK05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
SM05.10.2016
IE15.10.2016
LU15.10.2016
MT31.10.2016
BG05.01.2017
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2018/30]HU15.10.2013
AT05.10.2016
BE05.10.2016
CY05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
MK05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
SM05.10.2016
IE15.10.2016
LU15.10.2016
BG05.01.2017
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/51]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
SM05.10.2016
IE15.10.2016
LU15.10.2016
BG05.01.2017
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/41]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SK05.10.2016
SM05.10.2016
LU15.10.2016
BG05.01.2017
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/38]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SK05.10.2016
SM05.10.2016
BG05.01.2017
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/37]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SK05.10.2016
SM05.10.2016
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/36]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
RS05.10.2016
SE05.10.2016
SK05.10.2016
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/34]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RS05.10.2016
SE05.10.2016
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/33]AT05.10.2016
BE05.10.2016
DK05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RS05.10.2016
SE05.10.2016
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/26]AT05.10.2016
BE05.10.2016
FI05.10.2016
HR05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
RS05.10.2016
SE05.10.2016
NO05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/12]LV05.10.2016
BE31.10.2016
Cited inby applicant  EXPERT OPIN. THER. PATENTS, vol. 12, no. 12, 2002
   SCHLAEGER; CHRISTENSEN, CYTOTECHNOLOGY, vol. 15, 1998, pages 1 - 13
   E.-J. SCHLAEGER; K. CHRISTENSEN, CYTOTECHNOLOGY, vol. 15, 1998, pages 1 - 13
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.